CIDRAP newsletters options
Experts approve the vaccine in children 5 to 11 on an emergency use basis.
Also, a new report says failures with the global response include inequality, inaction, and political division.
Business groups are pleading with the Biden administration to delay mandates for private firms till after the holiday season.
Understanding the role of social gatherings in community spread has important implications for colleges, the author says.
A guaranteed $25 cash card for both vaccine recipients and drivers of vaccine recipients lessened slowing COVID-19 vaccine uptake at participating sites in North Carolina, according to a research letter in JAMA Internal Medicine yesterday.
Positive pneumococcal urinary antigen testing (PUAT) results among patients hospitalized with community-acquired pneumonia (CAP) was associated with earlier time to de-escalation of antibiotics, according to a single-center study published last week in Open Forum Infectious Diseases.
Most federal relief funds went to the already best-resourced facilities, one study finds.
The news comes as Russia reports a daily high in cases and Germany sees rising infections.
Also, Moderna announces promising immune response and safety data for its vaccine in kids ages 6 to 11.
First responders' risk for COVID-19 infection is about 60% more than other essential workers, including healthcare workers (HCWs), according to a study published late last week in JAMA Health Forum.
The Pan American Health Organization (PAHO) is calling for increased surveillance and investigation of carbapenemase-producing Enterobacterales in Latin America and the Caribbean.
Also, FDA documents show the Pfizer vaccine is 91% effective in younger kids.
Cognitive impairment patterns occurred in relatively young patients and echoed findings seen in those who recovered from other viral illnesses.
Preliminary data from a phase 3 trial in three countries was released this week at an international conference.
Rises in the UK have been a bellwether for emerging patterns in the United States.
The agency will not act as a stand-alone regulatory body, but as a coordinator.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
Originally published by CIDRAP News Oct 21
The Centers for Disease Control and Prevention (CDC) said today that lab tests have identified a rare, potentially deadly bacterium in an aromatherapy spray.
Two recent studies in Pediatrics look at risk factors for severe pediatric COVID-19 and COVID deaths in those younger than 21 years of age.
Experts say antibiotic resistance is a "complex web of related problems" that will require a One Health response.
